LIVER MANIFESTATIONS IN COVID-19 AND THE INFLUENCE OF PRE-EXISTING LIVER DISEASE IN THE COURSE OF THE INFECTION
Author(s) -
María Fernanda Guerra Veloz,
P. Ruíz,
Maria Jose Rios Villegas,
Pilar Del Pino Bellido,
José María Bravo-Ferrer,
Rocio Galves Cordero,
Maria Lorena Cadena Herrera,
Carmen Vías Parrado,
Francisco Bellido Muñoz,
Francisco Vega Rodríguez,
Ángel Caunedo Álvarez,
Jesús RodríguezBaño,
Isabel Carmona Soria
Publication year - 2020
Publication title -
revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2020.7627/2020
Subject(s) - medicine , gastroenterology , cirrhosis , diabetes mellitus , concomitant , fatty liver , chronic liver disease , liver disease , alcoholic liver disease , retrospective cohort study , copd , disease , endocrinology
patients with advanced chronic liver disease (CLD) may be at an increased risk of a severe course due to cirrhosis-associated immune dysfunction. The aim of this study was to determine the prevalence of CLD in COVID-19 patients and to analyze the course of the infection, compared with patients with non-liver disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom